Systemic complications of posterior subtenon injection of triamcinolone acetonide in type 2 diabetes patients.
We evaluated the influence of posterior subtenon injection of triamcinolone acetonide on blood glucose and blood pressure in type 2 diabetes patients. This treatment, in this limited series, did not significantly increase HbA1c levels or blood pressures. But spike-like increases of fasting blood glucose were observed in some cases.
Toda
Junko
J
Department of Ophthalmology, University of Tokyo, School of Medicine, Bunkyo-ku, Tokyo, Japan. jtoda-tky@umin.ac.jp
Fukushima
Harumi
H
Kato
Satoshi
S
D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005215:Fasting; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007267:Injections; D007328:Insulin / Q000627:therapeutic use; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*
D001786:Blood Glucose; D005938:Glucocorticoids; D006442:Glycated Hemoglobin; D007328:Insulin; D014222:Triamcinolone Acetonide